Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma

被引：4
|
作者：
Gray, Steven G. [1 ]
Meirson, Tomer [2 ]
Mutti, Luciano [3 ,4 ]
机构：
[1] St James Hosp, Trinity St Jamess Canc Inst, Thorac Oncol Res Grp, Dublin, Ireland
[2] Beilinson Med Ctr, Davidoff Canc Ctr, Rabin Med Ctr, Petah Tiqwa, Israel
[3] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Coppito Bldg,Second Floor Via Vetorio SNC, I-67100 Laquila, Italy
[4] Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Sbarro Hlth Res Org, Philadelphia, PA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 04期
关键词：
MALIGNANT PLEURAL MESOTHELIOMA; THORACIC ONCOLOGY PLATFORM; CHEMOTHERAPY; PEMBROLIZUMAB;
D O I：
10.1016/j.jtho.2024.01.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：541 / 546
页数：6
相关论文
共 50 条
  • [1] Immunotherapy Is a Good Standard Option for Patients With Malignant Pleural Mesothelioma, Despite the Real-World Results From Australia
    Smesseim, Illaa
    Baas, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (04) : 547 - 550
  • [2] Real World Outcomes of Immunotherapy (IO) for Pleural MESOthelioma in Australia - RIOMeso
    McNamee, N.
    Harvey, C.
    Gray, L.
    Khoo, T.
    Lingam, L.
    Zhang, B.
    Clay, T.
    Arulananda, S.
    Itchins, M.
    Pavlakis, N.
    Kao, S.
    Bowyer, S.
    Chin, V.
    Warburton, L.
    da Silva, I.
    John, T.
    Solomon, B.
    Alexander, M.
    Nagrial, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S163 - S163
  • [3] Real-World Immunotherapy Use in Pleural Mesothelioma: Insights & Immunological Landscape
    Xu, X.
    Shou, J.
    Wang, D.
    Ye, L.
    Fang, Y.
    Fang, M.
    Mao, W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S277 - S277
  • [4] VOLUNTARY PROVISION OF A PUBLIC GOOD - RESULTS FROM A REAL-WORLD EXPERIMENT
    POMMEREHNE, WW
    FELD, LP
    HART, A
    KYKLOS, 1994, 47 (04) : 505 - 518
  • [5] Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma
    Dumoulin, D. W.
    Douma, L. H.
    Hofman, M. M.
    van der Noort, V.
    Cornelissen, R.
    de Gooijer, C. J.
    Burgers, J. A.
    Aerts, J. G. J. V.
    LUNG CANCER, 2024, 187
  • [6] Real-world efficacy and toxicity of combination immunotherapy in mesothelioma: North East of England experience
    Elgendy, M.
    Mohammed, A.
    Yogalingam, K.
    Burns, A.
    Gardiner, J.
    Hall, S.
    Greystoke, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1116 - S1116
  • [7] Balancing real-world problems with real-world results
    Gordon, R
    PHI DELTA KAPPAN, 1998, 79 (05) : 390 - 393
  • [8] Real-world Results
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (17): : 1665 - 1665
  • [9] Real-world results
    Frank, Franziska
    NATURE, 2018, 557 (7703) : 130 - 130
  • [10] Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund
    Cerbone, Luigi
    Delfanti, Sara
    Crivellari, Stefania
    De Angelis, Antonina Maria
    Mazzeo, Laura
    Proto, Claudia
    Occhipinti, Mario
    Lo Russo, Giuseppe
    Dellepiane, Chiara
    Biello, Federica
    Alabiso, Irene
    Verderame, Francesco
    Gauna, Roberta
    De Simone, Irene
    Cuppone, Federica
    Petraglia, Sandra
    Pasello, Giulia
    Ceresoli, Giovanni Luca
    Garassino, Marina Chiara
    Torri, Valter
    Grosso, Federica
    TUMORI JOURNAL, 2024, 110 (03): : 168 - 173
12345